The COVID-19 pandemic has placed a tremendous burden on the healthcare system, resulting in the postponement of elective surgical procedures to preserve limited hospital resources and minimize viral transmission.
HealthDay
Actress Angelina Jolie's decision to undergo breast removal to reduce her risk of breast cancer has led other women to do so, a new study shows.
The findings show that celebrities can influence the health care decisions of the general public, said study author Art Sedrakyan, a professor at Weill Cornell Medicine in New York City.
>In early 2013, Jolie announced her decision to have the preventive surgery to have both breasts removed due to her elevated genetic risk for breast cancer.
Researchers sought to determine the impact of that news by analyzing 2004-2014 data on risk-reducing mastectomy in New York State and New South Wales in Australia.
In New York, they found the number of women undergoing the procedure nearly doubled — rising from 3.3 bimonthly cases per 1 million 20 months before Jolie's announcement to 6.3 cases per 1 million 20 months after her announcement.
The findings were similar in New South Wales, according to the study. The results were published in late September in the journal Health Services Research.
"This is an important area of research that health care providers and policymakers need to pay attention to," Sedrakyan said in a Weill Cornell news release.
"If celebrities are going to act on genetic testing and announce their treatment choices, then we should get prepared on our end to assess public health impact," he added.
A 2015 study also found an increase in preventive mastectomy after Jolie's announcement. And previous studies showed that breast imaging among women aged 25 to 44 rose after Australian singer Kylie Minogue's 2005 breast cancer diagnosis.
You Might Also Enjoy...
The COVID-19 pandemic has placed a tremendous burden on the healthcare system, resulting in the postponement of elective surgical procedures to preserve limited hospital resources and minimize viral transmission.
While no one is immune to the COVID-19 virus or the collateral damage that it has caused, breast cancer patient may be particularly concerned about the impact of this crisis on their efforts to maintain their breast and overall health.
Dr. Holmes point of view on the JAMA Oncology editorial that discusses advantages and disadvantages of de-escalating breast cancer surgery.
Read Dr. Holmes response to a cryoablation article where a surgeon in Palm Springs, CA received probation for offering cryoablation as an alternative to surgery for early stage breast cancer.
It is with great pleasure that I announce the publication of the long-term results of the TARGIT-A Trial, a clinical trial that compared partial breast single dose targeted intraoperative radiotherapy (IORT) to 3-6 week post-operative whole breast...
In the first edition of this guide, the world was just getting a handle on the impact that Coronavirus (COVID-19) would have on our daily lives. Things are quite a bit more clear now. For far too many in the U.S., the impact has been monumental...